Albemarle Corp (ALB) - Net Assets
Based on the latest financial reports, Albemarle Corp (ALB) has net assets worth $9.78 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.37 Billion) and total liabilities ($6.59 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.78 Billion |
| % of Total Assets | 59.74% |
| Annual Growth Rate | 8.59% |
| 5-Year Change | 68.48% |
| 10-Year Change | 148.1% |
| Growth Volatility | 25.96 |
Albemarle Corp - Net Assets Trend (1993–2025)
This chart illustrates how Albemarle Corp's net assets have evolved over time, based on quarterly financial data. Also explore ALB current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Albemarle Corp (1993–2025)
The table below shows the annual net assets of Albemarle Corp from 1993 to 2025. For live valuation and market cap data, see Albemarle Corp (ALB) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $9.78 Billion | -4.10% |
| 2024-12-31 | $10.20 Billion | +5.53% |
| 2023-12-31 | $9.67 Billion | +18.00% |
| 2022-12-31 | $8.19 Billion | +41.09% |
| 2021-12-31 | $5.81 Billion | +29.92% |
| 2020-12-31 | $4.47 Billion | +9.16% |
| 2019-12-31 | $4.09 Billion | +8.90% |
| 2018-12-31 | $3.76 Billion | -1.53% |
| 2017-12-31 | $3.82 Billion | -3.17% |
| 2016-12-31 | $3.94 Billion | +15.91% |
| 2015-12-31 | $3.40 Billion | +128.49% |
| 2014-12-31 | $1.49 Billion | -14.58% |
| 2013-12-31 | $1.74 Billion | -9.79% |
| 2012-12-31 | $1.93 Billion | +15.08% |
| 2011-12-31 | $1.68 Billion | +13.76% |
| 2010-12-31 | $1.48 Billion | +17.75% |
| 2009-12-31 | $1.25 Billion | +17.60% |
| 2008-12-31 | $1.07 Billion | -20.03% |
| 2007-12-31 | $1.33 Billion | +29.62% |
| 2006-12-31 | $1.03 Billion | +10.52% |
| 2005-12-31 | $930.27 Million | +30.77% |
| 2004-12-31 | $711.38 Million | +11.81% |
| 2003-12-31 | $636.22 Million | +11.67% |
| 2002-12-31 | $569.74 Million | -3.97% |
| 2001-12-31 | $593.30 Million | +6.15% |
| 2000-12-31 | $558.91 Million | +13.93% |
| 1999-12-31 | $490.56 Million | +8.61% |
| 1998-12-31 | $451.67 Million | -12.69% |
| 1997-12-31 | $517.34 Million | +2.40% |
| 1996-12-31 | $505.20 Million | -18.86% |
| 1995-12-31 | $622.60 Million | +14.24% |
| 1994-12-31 | $545.00 Million | -22.17% |
| 1993-12-31 | $700.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Albemarle Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 461367600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.61 Billion | 48.40% |
| Common Stock | $1.18 Million | 0.01% |
| Other Comprehensive Income | $-334.81 Million | -3.51% |
| Other Components | $5.25 Billion | 55.10% |
| Total Equity | $9.53 Billion | 100.00% |
Albemarle Corp Competitors by Market Cap
The table below lists competitors of Albemarle Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MTU Aero Engines AG
XETRA:MTX
|
$19.80 Billion |
|
Telus Corp
TO:T
|
$19.82 Billion |
|
Liberty Media Corporation Series C Liberty Formula One Common Stock
NASDAQ:FWONK
|
$19.83 Billion |
|
Allegheny Technologies Incorporated
NYSE:ATI
|
$19.84 Billion |
|
EXACT Sciences Corporation
NASDAQ:EXAS
|
$19.80 Billion |
|
Qingdao Haier Co Ltd
SHG:600690
|
$19.75 Billion |
|
Banco Bradesco S.A
F:BREC
|
$19.74 Billion |
|
New China Life Insurance Co Ltd
SHG:601336
|
$19.74 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Albemarle Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,961,517,000 to 9,533,365,000, a change of -428,152,000 (-4.3%).
- Net loss of 510,628,000 reduced equity.
- Dividend payments of 357,280,000 reduced retained earnings.
- Share repurchases of 3,240,000 reduced equity.
- Other comprehensive income increased equity by 407,255,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-510.63 Million | -5.36% |
| Dividends Paid | $357.28 Million | -3.75% |
| Share Repurchases | $3.24 Million | -0.03% |
| Other Comprehensive Income | $407.25 Million | +4.27% |
| Other Changes | $35.74 Million | +0.37% |
| Total Change | $- | -4.30% |
Book Value vs Market Value Analysis
This analysis compares Albemarle Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.38x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 32.41x to 2.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $5.94 | $192.61 | x |
| 1994-12-31 | $4.20 | $192.61 | x |
| 1995-12-31 | $4.70 | $192.61 | x |
| 1996-12-31 | $4.29 | $192.61 | x |
| 1997-12-31 | $4.66 | $192.61 | x |
| 1998-12-31 | $4.33 | $192.61 | x |
| 1999-12-31 | $5.16 | $192.61 | x |
| 2000-12-31 | $6.00 | $192.61 | x |
| 2001-12-31 | $6.38 | $192.61 | x |
| 2002-12-31 | $6.60 | $192.61 | x |
| 2003-12-31 | $7.55 | $192.61 | x |
| 2004-12-31 | $8.36 | $192.61 | x |
| 2005-12-31 | $9.74 | $192.61 | x |
| 2006-12-31 | $10.58 | $192.61 | x |
| 2007-12-31 | $13.15 | $192.61 | x |
| 2008-12-31 | $11.52 | $192.61 | x |
| 2009-12-31 | $13.10 | $192.61 | x |
| 2010-12-31 | $15.36 | $192.61 | x |
| 2011-12-31 | $17.39 | $192.61 | x |
| 2012-12-31 | $20.40 | $192.61 | x |
| 2013-12-31 | $19.30 | $192.61 | x |
| 2014-12-31 | $17.19 | $192.61 | x |
| 2015-12-31 | $29.17 | $192.61 | x |
| 2016-12-31 | $33.51 | $192.61 | x |
| 2017-12-31 | $32.70 | $192.61 | x |
| 2018-12-31 | $32.76 | $192.61 | x |
| 2019-12-31 | $36.98 | $192.61 | x |
| 2020-12-31 | $39.96 | $192.61 | x |
| 2021-12-31 | $48.27 | $192.61 | x |
| 2022-12-31 | $67.77 | $192.61 | x |
| 2023-12-31 | $79.92 | $192.61 | x |
| 2024-12-31 | $84.77 | $192.61 | x |
| 2025-12-31 | $81.00 | $192.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Albemarle Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.93%
- • Asset Turnover: 0.31x
- • Equity Multiplier: 1.72x
- Recent ROE (-5.36%) is below the historical average (13.70%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 3.11% | 2.41% | 0.83x | 1.55x | $-48.22 Million |
| 1994 | 9.41% | 4.75% | 0.95x | 2.09x | $-3.20 Million |
| 1995 | 12.56% | 6.29% | 1.03x | 1.93x | $15.94 Million |
| 1996 | 30.90% | 18.27% | 1.01x | 1.68x | $105.58 Million |
| 1997 | 15.46% | 9.64% | 0.93x | 1.72x | $28.27 Million |
| 1998 | 18.75% | 10.32% | 0.88x | 2.08x | $39.53 Million |
| 1999 | 18.10% | 10.50% | 0.89x | 1.94x | $39.74 Million |
| 2000 | 18.21% | 11.09% | 0.93x | 1.76x | $45.89 Million |
| 2001 | 11.49% | 7.23% | 0.83x | 1.90x | $8.84 Million |
| 2002 | 12.82% | 7.24% | 0.84x | 2.09x | $16.05 Million |
| 2003 | 11.31% | 6.48% | 0.80x | 2.18x | $8.32 Million |
| 2004 | 7.71% | 3.62% | 0.62x | 3.43x | $-16.30 Million |
| 2005 | 12.35% | 5.45% | 0.83x | 2.74x | $21.84 Million |
| 2006 | 13.91% | 6.04% | 0.94x | 2.46x | $40.16 Million |
| 2007 | 17.97% | 9.83% | 0.83x | 2.21x | $101.86 Million |
| 2008 | 18.22% | 7.87% | 0.87x | 2.67x | $87.62 Million |
| 2009 | 14.79% | 8.89% | 0.72x | 2.30x | $57.80 Million |
| 2010 | 22.30% | 13.36% | 0.77x | 2.17x | $174.17 Million |
| 2011 | 24.64% | 13.67% | 0.90x | 2.01x | $232.99 Million |
| 2012 | 16.99% | 12.37% | 0.73x | 1.87x | $128.18 Million |
| 2013 | 25.39% | 17.26% | 0.67x | 2.20x | $250.43 Million |
| 2014 | 9.81% | 5.45% | 0.47x | 3.84x | $-2.63 Million |
| 2015 | 10.29% | 11.85% | 0.29x | 2.95x | $9.47 Million |
| 2016 | 16.96% | 24.04% | 0.33x | 2.15x | $264.17 Million |
| 2017 | 1.49% | 1.79% | 0.40x | 2.11x | $-312.60 Million |
| 2018 | 19.34% | 20.55% | 0.45x | 2.11x | $335.03 Million |
| 2019 | 13.56% | 14.86% | 0.36x | 2.51x | $140.00 Million |
| 2020 | 8.80% | 12.01% | 0.30x | 2.45x | $-51.06 Million |
| 2021 | 2.20% | 3.72% | 0.30x | 1.95x | $-438.85 Million |
| 2022 | 33.70% | 36.75% | 0.47x | 1.94x | $1.89 Billion |
| 2023 | 16.72% | 16.36% | 0.53x | 1.94x | $632.26 Million |
| 2024 | -11.84% | -21.93% | 0.32x | 1.67x | $-2.18 Billion |
| 2025 | -5.36% | -9.93% | 0.31x | 1.72x | $-1.46 Billion |
Industry Comparison
This section compares Albemarle Corp's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,003,375,394
- Average return on equity (ROE) among peers: 2.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Albemarle Corp (ALB) | $9.78 Billion | 3.11% | 0.67x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $4.98 Million | -32.65% | 0.10x | $212.84 Million |
| Aemetis Inc (AMTX) | $-201.85 Million | 0.00% | 0.00x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $2.10 Billion | 12.92% | 1.14x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.71 Billion | 13.97% | 1.77x | $2.50 Billion |
| Avient Corp (AVNT) | $2.34 Billion | 3.24% | 1.55x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.14 Billion | 8.03% | 4.13x | $6.08 Billion |
| Balchem Corporation (BCPC) | $938.28 Million | 11.23% | 0.73x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $1.52 Million | 1.74% | 0.09x | $4.73 Million |
| Bon Natural Life Ltd (BON) | $4.55 Million | 4.91% | 2.66x | $7.17 Million |
About Albemarle Corp
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greas… Read more